Endoscopic mucosal resection in the treatment of Barrett's Esophagus
Keywords:
endoscopic mucosal resection, Barrett esophagusAbstract
Introduction: endoscopic mucosal resection is a useful technique in the treatment of dysplasia and carcinoma in situ associated with Barrett's oesophagus. It improves the quality of the diagnosis by the possibility of obtaining a larger sample of tissue for histological study, it allows to delimit the presence of lesion at the edges and the invasion to deep planes and favours decision making.Objective: to show different aspects related to endoscopic mucosal resection in order to improve the knowledge of the specialists and to improve its application.
Methods: the search for the information was done through PubMed and Google Academic. We consulted, mainly, scientific journals of the last years contained in the Medline database, others of similar quality but not part of Medline and some theses.
Results: gastroesophageal reflux disease is the main risk factor of Barretten's esophagus, and symptoms can go unnoticed.
Conclusions: this technique is a fundamental tool in the early treatment of dysplastic changes, which are currently not very widespread, despite the fact that its technical requirements are simple.
Downloads
References
1.Sharma P, Sampliner R, Ilson D. Esophageal cancer and Barrett’s esophagus. 3th ed. Estados Unidos; Wiley-Blackwell; 2015.
2.Soetikno R, Kaltenbach T, Yeh R, Gotoda T. Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract. J Clin Oncol [Internet]. 2005 Jul [citado 20/1/2020];23(20):4490-98. Disponible en: https://pubmed.ncbi.nlm.nih.gov/16002839/. https://doi.org/10.1200/jco.2005.19.935
3.Sampliner RE, editor. Endoscopic Therapy for Barrett’s Esophagus [Internet]. Estados Unidos: Humana Press; 2009 [citado 20/1/2020]. Disponible en: https://link.springer.com/content/pdf/10.1007/978-1-60327-445-6.pdf
4.Amadi C, Gatenby P. Barrett's oesophagus: Current controversies. World J Gastroenterol [Internet]. 2017 Jul [citado 20/1/2020];23(28):5051-67. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/PMC5537175/. https://dx.doi.org/10.3748/wjg.v23.i28.5051
5.Clermont M, Falk GW. Clinical guidelines update on the diagnosis and management of Barrett’s esophagus. Dig Dis Sci [Internet]. 2018 Aug [citado 20/1/2020];63(8):2122-8. Disponible en: https://link.springer.com/article/10.1007/s10620-018-5070-z
6.Naef AP, Savary M, Ozzello L. Columnar-lined lower esophagus: an acquired lesion with malignant predisposition. Report on 140 cases of Barrett’s esopha- gus with 12 adenocarcinomas. J Thorac Cardiovasc Surg [Internet]. 1975 Nov [citado 20/1/2020];70(5):826-35. Disponible en: https://pubmed.ncbi.nlm.nih.gov/1186274/
7.Offman J, Muldrew B, O'Donovan M, Debiram-Beecham I, Pesola F, Kaimi I, et al. Barrett's oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux. BMC Cancer [Internet]. 2018 Aug [citado 20/1/2020];18(1):784. Disponible en: https://bmccancer.biomedcentral.com/articles/10.1186/s12885-018-4664-3. https://doi.org/10.1186/s12885-018-4664-3
8.Robles Medranda C, Ferber Reyes FD. Caracterización clínica, endoscópica e histológica del esófago de barrett en pacientes adultos [tesis]. Guayaquil: Universidad de Especialidades Espiritu Santo; 2018 [citado 20/1/2020]. Disponible en: http://repositorio.uees.edu.ec/bitstream/123456789/2618/1/FERBER%20FEDERICO.pdf
9.Peláez-Luna M, Hernández-Guerrero AI, Valdovinos-Andraca F, Herrera-Esquivel JJ, Martínez-García CL, Aquino-Pérez S. Guías de diagnóstico, vigilancia y manejo del esófago de Barrett Asociación Mexicana de Endoscopia Gastrointestinal. Endoscopia [Internet]. 2017 Abr-Jun [citado 20/1/2020];29(2):97-112. Disponible en: http://revista.amegendoscopia.org.mx/index.php/endos/article/view/63/79
10.Shaheen NJ, Falk GW, Iyer PG, Gerson LB; American College of Gastroenterology. ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus. Am J Gastroenterol [Internet]. 2016 Jan [citado 20/1/2020];111(1):30-50. Disponible en: https://pubmed.ncbi.nlm.nih.gov/26526079/. https://doi.org/10.1038/ajg.2015.322. Erratum in: Am J Gastroenterol. 2016 Jul;111(7):1077. doi: 10.1038/ajg.2016.186
11.Geramizadeh B, Owen DA. Handling and pathology reporting of gastrointestinal endoscopic mucosal resection. Middle East J Dig Dis [Internet]. 2017 Jan [citado 20/1/2020];9(1):5-11. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308135/
12.Kothari S, Kaul V. Endoscopic mucosal resection and endoscopic submucosal dissection for endoscopic therapy of Barrett’s esophagus-related neoplasia. Gastroenterol Clin North Am [Internet]. 2015 Jun [citado 20/1/2020];44(2):317–35. Disponible en: https://www.clinicalkey.es/#!/content/playContent/1-s2.0-S0889855315000230. https://doi.org/10.1016/j.gtc.2015.02.006
13.Komanduri S, Raman Muthusamy, Wani S. Controversies in endoscopic eradication therapy for Barrett's esophagus. Gastroenterol [Internet]. 2018 May [citado 20/1/2020];154(7):1861-75. Disponible en: https://www.clinicalkey.es/#!/content/playContent/1-s2.0-S001650851830221X
14.Ge PS, Muthusamy VR. Endoscopic mucosal resection for Barrett's esophagus. J Laparoendosc Adv Surg Tech A [Internet]. 2017 Apr [citado 20/1/2020];27(4):404-411. Disponible en: https://mdanderson.elsevierpure.com/en/publications/endoscopic-mucosal-resection-for-barretts-esophagus. https://doi.org/10.1089/lap.2016.0532
15.Peters FP, Curvers WL, Rosmolen WD, De Vries CE, Ten Kate FJW, Krischnadath KK, et al. Surveillance history of endoscopically treated patients with early Barrett’s neoplasia: non-adherence to the Seattle biopsy protocol leads to sampling error. Dis Esophagus [Internet]. 2008 Sep [citado 20/1/2020];21(6):475–9. Disponible en: https://pubmed.ncbi.nlm.nih.gov/18430186/. https://doi.org/10.1111/j.1442-2050.2008.00813.x
16.Moss A, Bourke M, Hourigan L, Gupta S, Williams S, Tran K, et al. Endoscopic resection for Barrett’s high-grade dysplasia and early esophageal adenocarcinoma: an essential staging procedure with long-term therapeutic benefit. Am J Gastroenterol [Internet]. 2010 Jun [citado 20/1/2020];105(6):1276–83. Disponible en: https://insights.ovid.com/pubmed?pmid=20179694
17.Voltaggio L, Montgomery EA. Diagnosis and Management of Barrett-related neoplasia in the modern era. Surg Pathol Clin [Internet]. 2017 Dec [citado 20/1/2020];10(4):781-800. Disponible en: https://www.clinicalkey.es/#!/content/playContent/1-s2.0-S187591811730106X
18.Song J, Zhang J, Wang J, Guo X, Yu S, Wang J, et al. Meta-analysis of the effects of endoscopy with narrow band imaging in detecting dysplasia in Barrett’s esophagus. Dis Esophagus [Internet]. 2015 Aug-Sep [citado 20/1/2020];28(6):560–6. Disponible en: https://pubmed.ncbi.nlm.nih.gov/24758693/. https://doi.org/10.1111/dote.12222
19.Tholoor S, Bhattacharyya R, Tsagkournis O, Longcroft-Wheaton G, Bhandari P. Acetic acid chromoendoscopy in Barrett’s esophagus surveillance is superior to the standardized random biopsy protocol: results from a large cohort study (with video). Gastrointest Endosc [Internet]. 2014 Sep [citado 20/1/2020];80(3):417–24. Disponible en: https://www.clinicalkey.es/#!/content/playContent/1-s2.0-S0016510714001059
20.Evans RPT, Mourad MM, Fisher SG, Bramhall SR. Evolving management of metaplasia and dysplasia in Barrett's epithelium. World J Gastroenterol [Internet]. 2016 Dec [citado 20/1/2020];22(47):10316-24. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5175244/. https://doi.org/10.3748/wjg.v22.i47.10316
21.Singh T, Sanaka MR, Thota PN. Endoscopic therapy for Barrett's esophagus and early esophageal cancer: Where do we go from here? World J Gastrointest Endosc [Internet]. 2018 Sep [citado 20/1/2020];10(9):165-74. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162248/. https://dx.doi.org/10.4253/wjge.v10.i9.165
22.Chedgy FJQ, Kandiah K, Thayalasekaran S, Subramanian S, Bhandari P. Advances in the endoscopic diagnosis and treatment of Barrett’s neoplasia. F1000Res [Internet]. 2016 [citado 20/1/2020];5(F1000 Faculty Rev):113. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755403/. https://dx.doi.org/10.12688/f1000research.6996.1
23.Pech O MA, Manner H, Behran SA, Pohl J, Wefering M, et al. Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology [Internet]. 2014 Mar [citado 20/1/2020];146(3):652-60. Disponible en: https://www.clinicalkey.es/#!/content/playContent/1-s2.0-S0016508513015965
24.Anders M, Bähr C, El-Masry MA, Marx AH, Koch M, Seewald S, et al. Long-term recurrence of neoplasia and Barrett’s epithelium after complete endoscopic resection. Gut [Internet]. 2014 Oct [citado 20/1/2020];63(10):1535-43. Disponible en: https://gut.bmj.com/content/63/10/1535.long. http://dx.doi.org/10.1136/gutjnl-2013-305538
25.Wani S, Komanduri S, Muthusamy VR. Endoscopic eradication therapy in Barrett’s esophagus-related neoplasia: setting the bar right to optimize patient outcomes. Gastroenterol [Internet]. 2016 Mar [citado 20/1/2020];150(3):772–4. Disponible en: https://www.clinicalkey.es/#!/content/playContent/1-s2.0-S0016508516000883
26.Wolfsen HC. Radiofrequency ablation for the treatment of Barrett Esophagus with low-grade dysplasia. Gastroenterol Hepatol (NY) [Internet]. 2018 Aug [citado 15/2/2020];14(8):488-90. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170889/
27.Visrodia K, Zakko L, Wang KK. Radiofrequency Ablation of Barrett’s Esophagus. Gastrointest Endoscop Clin N Am [Internet]. 2017 Jul [citado 20/1/2020];27(3):491-501. Disponible en: https://www.clinicalkey.es/#!/content/playContent/1-s2.0-S1052515717300405
28.Tamayo-de la Cuesta JL. Esófago de Barrett. Rev Gastroenterol México [Internet]. 2018 [citado 20/1/2020];83(Supl 1):128-129. Disponible en: http://www.revistagastroenterologiamexico.org/index.php?p=revista&tipo=pdf-simple&pii=X0375090618630786
29.Pech O, Bollschweiler E, Manner H, Leers J, Ell C, Hölscher AH. Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett’s esophagus at two high-volume centers. Ann Surg [Internet]. 2011 Jul [citado 20/1/2020];254(1):67–72. Disponible en: https://pubmed.ncbi.nlm.nih.gov/21532466/. https://doi.org/10.1097/sla.0b013e31821d4bf6
30.Erbe Elektromedizin GmbH. Ablación del esófago de Barrett con HybridAPC [Internet]. Alemania: Erbe Elektromedizin GmbH; 2016 [citado 20/1/2020]. Disponible en: https://de.erbe-med.com/index.php?eID=dumpFile&t=f&f=35854&token=62d6871b74632c924560ae876aa13712f8dc3f67
31.Libânio D, Pimentel-Nunes P, Dinis-Ribeiro M. Complications of endoscopic resection techniques for upper GI tract lesions. Best Pract Res Clin Gastroenterol [Internet]. 2016 Oct [citado 20/1/2020];30(5):735-48. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27931633/. https://doi.org/10.1016/j.bpg.2016.09.010
32.Oliphant Z, Snow A, Knight H, Barr H, Almond LM. Endoscopic resection with or without mucosal ablation of high grade dysplasia and early oesophageal adenocarcinoma - long term follow up from a regional UK centre. Int J Surg [Internet]. 2014 Nov [citado 20/1/2020];12(11):1148–50. Disponible en: https://www.sciencedirect.com/science/article/pii/S1743919114008966. https://doi.org/10.1016/j.ijsu.2014.09.002
33.Desai M, Saligram S, Gupta N, Vennalaganti P, Bansal A, Choudhary A, et al. Efficacy and safety outcomes of multimodal endoscopic eradication therapy in Barrett’s esophagus-related neoplasia: a systematic review and pooled analysis. Gastrointest Endosc [Internet]. 2017 Mar [citado 20/1/2020];85(3):482–95. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27670227/. https://doi.org/10.1016/j.gie.2016.09.022
34.Tomizawa Y, Iyer PG, Wong Kee Song LM, Buttar NS, Lutzke LS, Wang KK. Safety of endoscopic mucosal resection for Barrett’ s esophagus. Am J Gastroenterol [Internet]. 2013 Sep [citado 20/1/2020];108(9):1440-47. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815637/. https://dx.doi.org/10.1038/ajg.2013.187
35.Qumseya B, Panossian AM, Rizk C, Cangemi D, Wolfsen C, Raimondo M, et al. Predictors of esophageal stricture formation post endoscopic mucosal resection. Clin Endosc [Internet]. 2014 Mar [citado 20/1/2020];47(2):155-61. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994258/. https://dx.doi.org/10.5946/ce.2014.47.2.155
36.Muñoz-Largacha JA, Litle VR. Endoscopic mucosal ablation and resection of Barrett's esophagus and related diseases. J Vis Surg [Internet]. 2017 Sep [citado 20/1/2020];3(9):128. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639009/. https://dx.doi.org/10.21037/jovs.2017.07.10
Downloads
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms:
- Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
- Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
- Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).